Foamix's Minocycline Foam: A Game Changer In Severe Acne?

A topical foam formulation of the antibiotic, minocycline, is expected to be a novel entrant into the US severe acne market. After positive top-line results from a confirmatory Phase III study, Foamix is stepping-up its financing and marketing plans.

SC1809_Game Changer_649587091_1200.jpg
A topical foam formulation will be a different option for severe acne • Source: Shutterstock

More from Clinical Trials

More from R&D